Characteristics of serogroup 20 S.pneumoniae isolates from Brazil

BMC Infectious Diseases

Table 2 Clinical manifestations of patients presenting with invasive disease caused by serogroup 20 S. pneumoniae isolates

ID#	Date^a	Origin	Source	Age	DM	SAH	HIV	Liver disease	COPD	Neoplasia	Smoking	Alcoholism	ICU	Death
009–07	pre	GHC	blood	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
044–09	pre	GHC	blood	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
045–09	pre	GHC	blood	85–89	no	yes	no	no	no	no	no	no	no	no
079–09	pre	GHC	CSF	55–59	no	yes	no	no	yes	no	yes	yes	no	no
014–11	pre	GHC	blood	70–74	yes	no	no	no	no	yes	no	no	no	no
056–11	post	GHC	blood	50–54	no	no	yes	no	no	no	no	no	no	no
089–11	post	HCPA	blood	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
103–11	post	HCPA	CSF	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
114–11	post	GHC	blood	70–74	yes	yes	no	no	yes	no	yes	no	no	no
121–11	post	GHC	blood	65–69	no	yes	no	no	yes	no	No	no	no	no
124–11	post	GHC	blood	65–69	no	no	no	yes	yes	no	yes	yes	yes	yes
130–11	post	GHC	blood	35–39	no	no	no	no	no	no	yes	yes	yes	no
136–11	post	GHC	blood	65–69	no	no	no	no	no	yes	yes	no	no	no
142–11	post	GHC	blood	75–79	no	no	no	no	no	yes	no	no	no	yes
161–11	post	HMD	blood	50–54	no	no	no	no	no	no	no	no	no	no
031–12	post	GHC	blood	80–84	yes	yes	no	no	no	no	no	no	no	no

^aDate is referred to periods pre-vaccination (from 2007 to 2010) and post-vaccination (from 2010 to 2012)
GHC Grupo Hospitalar Conceição, HCPA Hospital de Clínicas de Porto Alegre, HMD Hospital Mãe de Deus, NA not available, DM diabetes mellitus, SAH systemic arterial hypertension, COPD chronic obstructive pulmonary disease, ICU admission to intensive care unit

ISSN: 1471-2334